Literature DB >> 27554434

Good Cell Culture Practice for stem cells and stem-cell-derived models.

David Pamies1, Anna Bal-Price2, Anton Simeonov3, Danilo Tagle3, Dave Allen4, David Gerhold3, Dezhong Yin5, Francesca Pistollato2, Takashi Inutsuka6, Kristie Sullivan7, Glyn Stacey8, Harry Salem9, Marcel Leist10, Mardas Daneshian10, Mohan C Vemuri11, Richard McFarland12, Sandra Coecke2, Suzanne C Fitzpatrick12, Uma Lakshmipathy11, Amanda Mack13, Wen Bo Wang13, Daiju Yamazaki14, Yuko Sekino14, Yasunari Kanda14, Lena Smirnova1, Thomas Hartung1,10.   

Abstract

The first guidance on Good Cell Culture Practice (GCCP) dates back to 2005. This document expands this to include aspects of quality assurance for in vitro cell culture focusing on the increasingly diverse cell types and culture formats used in research, product development, testing and manufacture of biotechnology products and cell-based medicines. It provides a set of basic principles of best practice that can be used in training new personnel, reviewing and improving local procedures, and helping to assure standard practices and conditions for the comparison of data between laboratories and experimentation performed at different times. This includes recommendations for the documentation and reporting of culture conditions. It is intended as guidance to facilitate the generation of reliable data from cell culture systems, and is not intended to conflict with local or higher level legislation or regulatory requirements. It may not be possible to meet all recommendations in this guidance for practical, legal or other reasons. However, when it is necessary to divert from the principles of GCCP, the risk of decreasing the quality of work and the safety of laboratory staff should be addressed and any conclusions or alternative approaches justified. This workshop report is considered a first step toward a revised GCCP 2.0.

Entities:  

Keywords:  alternatives to animals; induced pluripotent stem cells; Good Cell Culture Practices; in vitro methods

Mesh:

Year:  2016        PMID: 27554434     DOI: 10.14573/altex.1607121

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  28 in total

1.  Proliferation characteristics of cells cultured under periodic versus static conditions.

Authors:  Daniel F Gilbert; Sepideh Abolpour Mofrad; Oliver Friedrich; Joachim Wiest
Journal:  Cytotechnology       Date:  2018-12-04       Impact factor: 2.058

2.  21st Century Cell Culture for 21st Century Toxicology.

Authors:  David Pamies; Thomas Hartung
Journal:  Chem Res Toxicol       Date:  2016-12-05       Impact factor: 3.739

Review 3.  Best practices for detecting and mitigating the risk of cell culture contaminants.

Authors:  Raymond W Nims; Paul J Price
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-12-01       Impact factor: 2.416

Review 4.  Stem cells and cell-based therapies for cerebral palsy: a call for rigor.

Authors:  Lauren L Jantzie; Joseph Scafidi; Shenandoah Robinson
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

Review 5.  'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologies.

Authors:  Dina Simkin; Christina Ambrosi; Kelly A Marshall; Luis A Williams; Jordyn Eisenberg; Mennat Gharib; Graham T Dempsey; Alfred L George; Owen B McManus; Evangelos Kiskinis
Journal:  Trends Pharmacol Sci       Date:  2022-05       Impact factor: 17.638

6.  Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development

Authors:  Uwe Marx; Takafumi Akabane; Tommy B Andersson; Elizabeth Baker; Mario Beilmann; Sonja Beken; Susanne Brendler-Schwaab; Murat Cirit; Rhiannon David; Eva-Maria Dehne; Isabell Durieux; Lorna Ewart; Suzanne C Fitzpatrick; Olivier Frey; Florian Fuchs; Linda G Griffith; Geraldine A Hamilton; Thomas Hartung; Julia Hoeng; Helena Hogberg; David J Hughes; Donald E Ingber; Anita Iskandar; Toshiyuki Kanamori; Hajime Kojima; Jochen Kuehnl; Marcel Leist; Bo Li; Peter Loskill; Donna L Mendrick; Thomas Neumann; Giorgia Pallocca; Ivan Rusyn; Lena Smirnova; Thomas Steger-Hartmann; Danilo A Tagle; Alexander Tonevitsky; Sergej Tsyb; Martin Trapecar; Bob Van de Water; Janny Van den Eijnden-van Raaij; Paul Vulto; Kengo Watanabe; Armin Wolf; Xiaobing Zhou; Adrian Roth
Journal:  ALTEX       Date:  2020-02-28       Impact factor: 6.043

Review 7.  Perspectives on In Vitro to In Vivo Extrapolations.

Authors:  Thomas Hartung
Journal:  Appl In Vitro Toxicol       Date:  2018-12-08

8.  Optimized Method to Improve Cell Activity in 3D Scaffolds Under a Dual Real-Time Dynamic Bioreactor System.

Authors:  Flavia Pedrini; Moema A Hausen; Eliana A R Duek
Journal:  Methods Mol Biol       Date:  2022

9.  Systems Toxicology: Real World Applications and Opportunities.

Authors:  Thomas Hartung; Rex E FitzGerald; Paul Jennings; Gary R Mirams; Manuel C Peitsch; Amin Rostami-Hodjegan; Imran Shah; Martin F Wilks; Shana J Sturla
Journal:  Chem Res Toxicol       Date:  2017-03-31       Impact factor: 3.739

Review 10.  The ascendance of microphysiological systems to solve the drug testing dilemma.

Authors:  Eva-Maria Dehne; Tobias Hasenberg; Uwe Marx
Journal:  Future Sci OA       Date:  2017-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.